About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 23715 record(s)
Req # A-2021-001144
Adverse Drug Reactions (ADRs) for RANITIDINE HYDROCHLORIDE. Report numbers: E2B_03623086, E2B_03745650, 940286.Organization: Health Canada
March 2022
Req # A-2021-001146
Adverse Drug Reactions (ADRs) for RASBURICASE. Report numbers: 927873, 942071.Organization: Health Canada
March 2022
Req # A-2021-001163
Adverse Drug Reactions (ADRs) for DUPILUMAB. Report numbers: E2B_03829754, 927592, 933958, 940761.Organization: Health Canada
March 2022
Req # A-2021-001167
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_03840947, E2B_03532975, E2B_03844380, E2B_03847954, E2B_03924217, E2B_03611178, E2B_03830784, E2B_03630498, E2B_03840727, E2B_03954567, E2B_03955384, E2B_04015182.Organization: Health Canada
March 2022
Req # A-2021-001172
Adverse Drug Reaction (ADR). Report number: 000956223.Organization: Health Canada
March 2022
Req # A-2021-001201
Adverse Drug Reactions (ADRs) for Atenolol. Report numbers: E2B_02276106, E2B_02800976, E2B_02818186, E2B_02859979, E2B_02886137, E2B_02886197, E2B_03018272, E2B_03077510, E2B_03758004, E2B_03231735, E2B_03282001, E2B_03309237, E2B_03382225,…Organization: Health Canada
March 2022
Req # A-2021-001204
Adverse Drug Reactions (ADRs) for Pravastatin. Report numbers: E2B_03755570, 933597, 946274, E2B_00005765, E2B_01441164, E2B_01441318, E2B_02628891, E2B_03235387, E2B_03374885, E2B_03380701, E2B_03383328, E2B_03443811, E2B_03459128, E2B_03474794,…Organization: Health Canada
March 2022
Req # A-2021-001211
Adverse Drug Reactions (ADRs) for Furosemide. Report numbers: 944049, 944717, 945375, 945584, E2B_02680447, 950278, 950493, 951343, 958454, 959498, E2B_00519002, E2B_00534081, E2B_00556255, E2B_00798954, E2B_00840052, E2B_01595534, E2B_01652596,…Organization: Health Canada
March 2022
Req # A-2021-001265
Adverse Drug Reactions (ADRs) for RANITIDINE. Report numbers: E2B_03763402, 943113, E2B_03901491, E2B_03866242, E2B_03594792, E2B_03723458, E2B_03788263, 955817.Organization: Health Canada
March 2022
Req # A-2021-001270
Adverse Drug Reactions (ADRs) for RANITIDINE HYDROCHLORIDE. Report numbers: E2B_03550160, E2B_03840247, E2B_04324066, E2B_02559455, E2B_03587366, E2B_03627387, E2B_03976480, E2B_01270122, E2B_01687167, E2B_03570635, 940796, E2B_03950785.Organization: Health Canada
March 2022